Advertisement
Screener

Sofinnova Investments, Inc. Historic Quarter Change: Foreign Stocks, Added

Sofinnova Investments, Inc. historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Sofinnova Investments, Inc. opened 3 positions, added to 7, reduced 3 and sold out of 5.

  • Q2 2026: Stock GMAB; Country of operation —; Class SPONSORED ADS; Shares before 752,261.
  • Q1 2025: Stock GPCR; Country of operation United States; Class SPONSORED ADS; Shares before 20,892.
  • Q3 2024: Stock NVO; Country of operation —; Class ADR; Shares before 649,541.
  • Q3 2024: Stock GPCR; Country of operation United States; Class SPONSORED ADS; Shares before 8,915.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1631134), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-09); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2018-03-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026GMAB
Genmab A/S
SPONSORED ADS752,2614,045,215+3,292,954$20,183,163$111,122,056+$90,938,8932026-08-14
Q1 2025GPCR
Structure Therapeutics Inc
United StatesSPONSORED ADS20,89234,952+14,060$566,591$605,019+$38,4282025-05-15
Q3 2024NVO
Novo-Nordisk A S
ADR649,541726,329+76,788$92,715,482$86,483,994-$6,231,4882024-11-13
Q3 2024GPCR
Structure Therapeutics Inc
United StatesSPONSORED ADS8,91538,792+29,877$350,092$1,702,581+$1,352,4892024-11-13
Q2 2024NVO
Novo-Nordisk A S
ADR611,884649,541+37,657$78,565,906$92,715,482+$14,149,5762024-08-09
Q2 2024GPCR
Structure Therapeutics Inc
United StatesSPONSORED ADS8,7338,915+182$374,296$350,092-$24,2042024-08-09
Q1 2024ARGX
Argenx SE
SPONSORED ADR44,721149,300+104,579$17,013,210$58,782,396+$41,769,1862024-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
AMAZON COM INCUnited States$2.632B5
Lombard Odier Asset Management (Switzerland) SASwitzerland$2.632B452
FIRST MERCHANTS CORPUnited States$2.629B501
INTEGRITY ALLIANCE, LLC.United States$2.635B756
Waratah Capital Advisors Ltd.Canada$2.625B127
Advance Capital Management, Inc.United States$2.639B185
NFJ INVESTMENT GROUP, LLCUnited States$2.640B388
Wharton Business Group, LLCUnited States$2.647B141
Cerberus Capital Management, L.P.United States$2.648B14
PARADIGM CAPITAL MANAGEMENT INC/NYUnited States$2.614B174